Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection
- 1 December 2019
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 150, 104502
Abstract
No abstract availableKeywords
Funding Information
- U.S. National Institute of Health
- Institute of General Medical Sciences (GM123345, GM12171, 5T32GM108554-05, GM119197)
This publication has 124 references indexed in Scilit:
- Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid productionProceedings of the National Academy of Sciences, 2013
- Comprehensive Peptidomimetic Libraries Targeting Protein–Protein InteractionsAccounts of Chemical Research, 2012
- Systems biology approaches to toll‐like receptor signalingWIREs Mechanisms of Disease, 2012
- Sepsis: Something old, something new, and a systems viewJournal of Critical Care, 2012
- The Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose MetabolismCell Metabolism, 2012
- Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 AgonistScience Signaling, 2012
- The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid A Augments Innate Host Resistance to Systemic Bacterial InfectionInfection and Immunity, 2011
- Infectious Diseases in Patients with IRAK-4, MyD88, NEMO, or IκBα DeficiencyClinical Microbiology Reviews, 2011
- TLR signalling augments macrophage bactericidal activity through mitochondrial ROSNature, 2011
- The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transductionProceedings of the National Academy of Sciences, 2006